Key facts
- Smileyscope’s last known valuation is $53.0M (Mar 2025).
- It has raised $12.5M; the latest was Seed Round ($10.7M) in Mar 2025.
- Notable investors include LaunchVic, Breakthrough Victoria, Tanarra Capital, Access Capital Ventures, Australian Government (Landing Pads) — 17 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 17 names
- ·Watchlist + deal alerts for Smileyscope
- ·The full record, as it builds
Funding rounds
No funding rounds for Smileyscope are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Smileyscope
Developer of a virtual reality-based digital therapeutic platform designed to reduce pain and anxiety during medical procedures. The company provides an FDA-cleared VR system that reframes real-world procedural sensations into calming, supportive virtual experiences, enabling clinicians and hospitals to deliver drug-free pain and anxiety relief, reduce sedation, save clinical time, and improve patient throughput and satisfaction.
- Sector
- Healthcare
- HQ
- Melbourne, Australia
- Founded
- 2017
- Employees
- 19
- Website
- smileyscope.com/
- Ownership
- Privately Held (backing)
Smileyscope doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Smileyscope shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Smileyscope in its N-PORT filings yet. We sweep new filings monthly.